Business

Psychedelic Drugs Market Grows with Big Pharma Involvement

Updated 2026-07-19 14:55 UTC 1 source Positive

Eli Lilly's acquisition of AtaiBeckley signals a significant move in the market for psychedelic drugs used to treat mental health conditions. This marks an expansion into a previously stigmatized area by major pharmaceutical companies.

Coverage timeline — 1 article

CNBC

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.

2026-07-19 14:45 UTC